Clinical Trials on Hyperplasia Prostatic in Japan
Total 124 results
-
Astellas Pharma IncCompletedBenign Prostate HyperplasiaJapan
-
SanofiCompletedBenign Prostatic HyperplasiaJapan
-
Kissei Pharmaceutical Co., Ltd.Completed
-
SanofiCompletedBenign Prostatic HyperplasiaJapan
-
Eli Lilly and CompanyCompletedBenign Prostatic HyperplasiaJapan
-
Eli Lilly and CompanyCompletedBenign Prostatic HyperplasiaTaiwan, Japan
-
GlaxoSmithKlineCompletedProstatic HyperplasiaJapan
-
SanofiCompleted
-
Eli Lilly and CompanyNippon Shinyaku Co., Ltd.Completed
-
GlaxoSmithKlineCompleted
-
Eli Lilly and CompanyCompletedBenign Prostatic HyperplasiaKorea, Republic of, Japan
-
Astellas Pharma IncCompletedOveractive Bladder | Benign Prostatic Hyperplasia | Benign Prostatic HypertrophyJapan
-
GlaxoSmithKlineCompletedProstatic HyperplasiaKorea, Republic of, China, Japan, Taiwan
-
Taro Iguchi, MD, PHDAstellas Pharma IncCompleted
-
TakedaCompleted
-
Translational Research Center for Medical Innovation...Jikei University School of MedicineCompleted
-
Astellas Pharma IncMedivation LLC, a wholly owned subsidiary of Pfizer Inc.CompletedProstate Cancer | Prostate Neoplasms | Castration Resistant Prostate Cancer (CRPC)Japan
-
Iwate Medical UniversityHuman Genome Center, Institute of Medical Science, University of TokyoUnknown
-
Kindai UniversityJanssen Pharmaceutical K.K.RecruitingMetastatic Castration-sensitive Prostate CancerJapan
-
Taro Iguchi, MD, PHDBayer Yakuhin, Ltd.Active, not recruitingBone Metastases | Castration-resistant Prostate CancerJapan
-
Norio NonomuraUnknownCastration Resistant Prostate CancerJapan
-
Japan Study Group of Prostate CancerEnrolling by invitation
-
Astellas Pharma IncAstellas Pharma Singapore Pte. Ltd.Completed
-
Translational Research Center for Medical Innovation...Kyoto University, Graduate School of MedicineCompletedProstate Cancer | Metastatic CancerJapan
-
BayerRecruitingMetastatic Hormone-sensitive Prostate Cancer (mHSPC)Japan
-
Osamu UkimuraRecruiting
-
Translational Research Center for Medical Innovation...The Jikei University School of MedicineCompleted
-
Merck Sharp & Dohme LLCOrion Corporation, Orion PharmaActive, not recruitingProstatic Neoplasms | Metastatic Castration-Resistant Prostate CancerJapan
-
AstraZenecaCompleted
-
Osaka UniversityJapan Agency for Medical Research and DevelopmentRecruiting
-
Osamu UkimuraActive, not recruiting
-
Astellas Pharma IncCompletedProstate CancerJapan
-
Bristol-Myers SquibbCompleted
-
Janssen Pharmaceutical K.K.CompletedMetastatic Castration-Resistant Prostate CancerJapan
-
Translational Research Center for Medical Innovation...Kagawa UniversityCompleted
-
TakedaCompletedHormone Treatment-naïve Participants With Prostate CancerJapan
-
Novartis PharmaceuticalsCompletedCastration-resistant Prostate Cancer, Advanced Breast CancerJapan
-
Johnson & Johnson International (Singapore) Pte...CompletedHigh Risk Localized Prostate CancerJapan, Korea, Republic of, Taiwan
-
SanofiCompletedTherapy, Prostatic NeoplasmsJapan
-
Janssen Research & Development, LLCCompleted
-
Janssen Research & Development, LLCCompleted
-
SanofiCompleted
-
SanofiCompleted
-
Astellas Pharma IncPfizerCompletedCastration-resistant Prostate CancerJapan
-
Janssen Pharmaceutical K.K.CompletedProstatic Neoplasms, Castration-ResistantJapan
-
Novartis PharmaceuticalsEckert & Ziegler Radiopharma GmbHRecruitingProstate CancerJapan
-
BayerActive, not recruitingProstatic Neoplasms, Castration-ResistantJapan
-
Novartis PharmaceuticalsRecruitingOligometastatic Prostate Cancer (OMPC)Japan, Singapore, Canada, Israel, Switzerland, Australia, United States
-
SanofiCompleted
-
BayerCompleted